4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-063831
Chief Executive Officer sold 40,000 shares at an average $72.90 ($2,915,922)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2025-05-02 | Sale 10b5-1 | −18,480 | $72.52 | $1,340,146 | 2,963,505 | I |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-05-02 | Sale 10b5-1 | −21,520 | $73.22 | $1,575,776 | 2,941,985 | I |
| Open-market sales · 40,000 sh · avg $72.90 · $2,915,922 | |||||||
Loading xslF345X05/ownership.xml…